P3 Health Partners Inc. PIII
Set alert
3.94 USD -0.09 -2.18%
As of Nov 2, 2:38 PM ET
3.80 Day range 4.16
1.52 52-week range 16.89
- YTD
- +12.96%
- 1 year
- -54.95%
- Open
- 4.00
- Prev close
- 4.03
- Mkt cap
- 803.39M
- Vol
- 5.81K
- Avg vol
- 32.38K
- EPS
- -33.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.80
- High
- 4.16
- Forward P/E
- -23.57
- Beta
- 1.69
- Short ratio
- 1.19
- Inst. own
- 8.24%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 8.88
- 200-d avg
- 6.49
- 1y target
- 18.00
Key statistics
- Market cap
- 1.01B
- Enterprise value
- 360.08M
- Trailing P/E
- 0.00
- Forward P/E
- -23.57
- PEG ratio
- 0.00
- Price / sales
- 0.67
- Price / book
- 0.00
- EPS (TTM)
- -33.02
- Beta
- 1.69
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -6.55%
- Revenue (TTM)
- 1.50B
- Revenue growth
- 8.60%
- Free cash flow
- -124.25M
- Total cash
- 21.27M
- Total debt
- 130.69M
- Return on equity
- -192.58%
- Shares outstanding
- 3.91M
- Short % of float
- 0.88%
- 50-day average
- 8.88
- 200-day average
- 6.49
Analyst view
Consensus: none
Price target (mean) 18.00 +356.6% upside
Now 3.94
- Target (low)
- 13.00
- Target (mean)
- 18.00
- Target (high)
- 23.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 12, 2026
Expected Nov 12, 2026. Consensus EPS estimate 0.00.
Financials — quick view
PIII Revenue — quarterly 386.38M
PIII Net income — quarterly 7.44M
PIII EPS — quarterly -0.63
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sep 30, 2026 | -3.97 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | -1.89 | -0.63 | +1.26 | +66.67% |
| May 14, 2026 | Mar 31, 2026 | -4.85 | 0.32 | +5.17 | +106.60% |
| Mar 26, 2026 | Dec 31, 2025 | -8.06 | -23.02 | -14.96 | -185.49% |
| Nov 14, 2025 | Sep 30, 2025 | -5.29 | -9.67 | -4.38 | -82.71% |
| Aug 14, 2025 | Jun 30, 2025 | -3.29 | -6.23 | -2.94 | -89.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 22, 2026 | TD Cowen | main | Hold | Hold |
| May 15, 2026 | Lake Street | main | Buy | Buy |
| Apr 2, 2026 | TD Cowen | main | Hold | Hold |
| Mar 27, 2026 | Lake Street | main | Buy | Buy |
| Nov 17, 2025 | Lake Street | main | Buy | Buy |
| Apr 21, 2025 | Lake Street | main | Buy | Buy |
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- p3hp.org
News
- Head-To-Head Contrast: Tempus AI (NASDAQ:TEM) versus P3 Health Partners (NASDAQ:PIII)
- P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
- 20/20 Biolabs (NASDAQ:AIDX) and P3 Health Partners (NASDAQ:PIII) Head-To-Head Review
- P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
- P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
- Contrasting P3 Health Partners (NASDAQ:PIII) & McKesson (NYSE:MCK)
- Analyzing Molina Healthcare (NYSE:MOH) and P3 Health Partners (NASDAQ:PIII)
- Why Riot Platforms Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
- P3 Health Partners Q2 Earnings Call Highlights
- P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on PIII — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BACCHUS AMIR | Officer and Director | Stock Award(Grant) | Aug 3, 2023 | 2,256,490 |
| CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 12, 2024 | 0 |
| KAZARIAN GREGORY N | Director | Stock Award(Grant) | Oct 22, 2023 | 216,561 |
| LEAVITT LEGACY, L.L.C | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 23, 2024 | 0 |
| LEISURE LAWRENCE B. | Director | Stock Award(Grant) | Oct 22, 2023 | 216,561 |
| PARK JEFFREY G | Director | Stock Award(Grant) | Oct 22, 2023 | 216,561 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 1.40% | 54,717 | 270.85K | Jun 29, 2026 |
| Jane Street Group, LLC | 1.39% | 54,495 | 269.75K | Jun 29, 2026 |
| Vanguard Capital Management LLC | 1.06% | 41,484 | 205.34K | Jun 29, 2026 |
| Trinity Financial Advisors LLC | 0.86% | 33,540 | 166.02K | Jun 29, 2026 |
| MYDA Advisors LLC | 0.51% | 20,000 | 99.00K | Jun 29, 2026 |
| Corient Private Wealth LP | 0.50% | 19,737 | 97.70K | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.72% | 28,358 | 140.37K | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.33% | 12,974 | 64.22K | Jun 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.17% | 6,658 | 32.96K | Jul 30, 2026 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 0.08% | 3,210 | 15.89K | Jul 30, 2026 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 0.06% | 2,244 | 11.11K | Jul 30, 2026 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.03% | 1,284 | 6.36K | Jul 30, 2026 |